Login to Your Account

Abilify Falters Overseas: Piqued Hunger in Targacept Partnering?

By Randy Osborne

Tuesday, December 1, 2009
Investors must wait until probably next year to find out exactly what the withdrawal of Abilify's European marketing application means for Targacept Inc.'s chances overseas with lead asset TC-5214 in adjunctive depression therapy. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription